Ovid Therapeutics (OVID) Q4 2022 Earnings

13MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.25
-0.22
-0.19
-0.16

Details

Expected EPS
-0.18
Actual EPS
-0.16
Surprise EPS
0.02
Surprise Percent
+11.11%

Description

Ovid Therapeutics (OVID) has reported earnings of -0.16 per share for Q4 2022.

0 Comments

Share your thoughts